| BMI | body mass index |
| C/T | chemotherapy |
| C/T + local R/T | combined chemotherapy and local radiotherapy |
| CA19-9 | carbohydrate antigen 19-9 |
| CC | cancer cachexia |
| CI | confidence interval |
| CS + adj | conversion surgery with pre- or post-operative adjuvant chemotherapy |
| CT | computed tomography |
| EMRs | electronic medical records |
| Hb | hemoglobin |
| HR | hazard ratio |
| HU | hounsfield unit |
| IRB | Institutional Review Board |
| L3 | the third lumbar vertebrae |
| mOS | median overall survival |
| mPFS | median progression-free survival |
| Non-CC | negative cancer cachexia status |
| Non-SC | negative sarcopenia status |
| OR | odds ratio |
| OS | overall survival |
| PC | pancreatic cancer |
| PFS | progression-free survival |
| SC | sarcopenia |
| SO | sarcopenic obesity |
| TPA | total psoas area |